Search Crime Times:
Enter your search term(s) below:
Articles can also be accessed via the following directories:
~ Title
~ Issue Number
~ Full Page Listing
Survey:
Click here to let us
know how you feel
about our Newsletter
Our Mailing List:
Enter your email
address below to
receive notification
when a new issue
is available.

New research supports value of omega-3 supplements in reducing ADHD symptoms

Children with attention deficit hyperactivity disorder (ADHD) may improve markedly when they receive high doses of omega-3 fatty acids, according to new research that strongly supports several earlier findings.

In an eight-week, non-placebo-controlled trial, Paul Sorgi and colleagues administered eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) to nine children with ADHD. The children, six boys and three girls, ranged in age from 8 to 16; six had combined symptoms of hyperactivity, impulsivity, and attention problems, while three primarily had attention problems.

Halfway through the study the researchers adjusted each child’s dosage to target an optimal ratio of EPA to the omega-6 fatty acid arachidonic acid (AA) as measured in tests of blood plasma phospholipids. Both omega-3 and omega-6 fatty acids are essential to health, but the balance of the two is important.

Americans eat large amounts of omega-6 fatty acids and small amounts of omega-3’s—an imbalance many scientists believe contributes to both mental and physical problems. The researchers’ goal in this study was to reach or come close to the ratio of AA to EPA found in people in Japan, who eat much more balanced amounts of these two fatty acid groups.

Sorgi and colleagues report that supplementation resulted in significant increases in the children’s EPA and DHA levels, as well as a reduction in the ratio of AA to EPA. The children also showed reductions in inattention, hyperactivity, oppositional/defiant behavior, and conduct disorder. On average, the children’s “severity of illness” score, as measured by the Clinical Global Impression Scale, dropped from “moderately symptomatic” to “mildly symptomatic.” (The only two children who scored in the “markedly symptomatic” range at both the beginning and the end of the study were those who failed to take the supplements consistently.) Improvement occurred both in children taking ADHD medications and in those not undergoing drug treatment.

These findings are consistent with data from several other studies, among them:

Not all studies show improvements in ADHD symptoms following omega-3 supplementation. Sorgi says, “The inconsistent findings from previous studies and our results suggest that greater dosages of EPA are needed to decrease the AA:EPA ratio to levels similar to the Japanese population and to observe significant behavioral improvements.” (This study used starting dosages of 10.8 grams of EPA and 5.4 grams of DHA per day.)
Editor’s note: see related article, Crime Times, 2007, Vol. 13, No. 3, Page 7), of this issue.

----


“Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder,” Paul J. Sorgi, Edward M. Hallowell, Heather L. Hutchins, and Barry Sears, Nutrition Journal, Vol. 6, No. 16, 2007 (online publication). Address: Paul Sorgi, Hallowell Center, 142 North Road, Suite F 105, Sudbury, MA 01776, pjsorgi@aol.com.